Met Life Investment Management, LLC Amneal Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 94,937 shares of AMRX stock, worth $856,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,937
Previous 94,639
0.31%
Holding current value
$856,331
Previous $749,000
6.14%
% of portfolio
0.0%
Previous 0.0%
Shares
58 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
137MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA17.6MShares$158 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$102 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.8 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$67.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.37B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...